Varex Imaging Corporation (VREX): Price and Financial Metrics


Varex Imaging Corporation (VREX): $22.90

0.10 (+0.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

VREX POWR Grades


  • Value is the dimension where VREX ranks best; there it ranks ahead of 99.05% of US stocks.
  • VREX's strongest trending metric is Value; it's been moving up over the last 179 days.
  • VREX ranks lowest in Sentiment; there it ranks in the 18th percentile.

VREX Stock Summary

  • VREX's went public 5.16 years ago, making it older than merely 19.51% of listed US stocks we're tracking.
  • With a price/earnings ratio of 36.05, Varex Imaging Corp P/E ratio is greater than that of about 77.56% of stocks in our set with positive earnings.
  • In terms of twelve month growth in earnings before interest and taxes, Varex Imaging Corp is reporting a growth rate of -348.93%; that's higher than merely 5.65% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Varex Imaging Corp are CMBM, MCHX, CALX, WWD, and ESPR.
  • VREX's SEC filings can be seen here. And to visit Varex Imaging Corp's official web site, go to www.vareximaging.com.

VREX Valuation Summary

  • In comparison to the median Healthcare stock, VREX's price/sales ratio is 60.53% lower, now standing at 1.5.
  • VREX's EV/EBIT ratio has moved up 35.2 over the prior 56 months.
  • VREX's price/earnings ratio has moved down 79.8 over the prior 56 months.

Below are key valuation metrics over time for VREX.

Stock Date P/S P/B P/E EV/EBIT
VREX 2021-08-31 1.5 2.4 -64.9 44.4
VREX 2021-08-30 1.5 2.4 -64.3 44.0
VREX 2021-08-27 1.5 2.4 -63.7 43.7
VREX 2021-08-26 1.4 2.3 -61.7 42.7
VREX 2021-08-25 1.4 2.3 -61.8 42.8
VREX 2021-08-24 1.4 2.3 -62.1 42.9

VREX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VREX has a Quality Grade of C, ranking ahead of 59.48% of graded US stocks.
  • VREX's asset turnover comes in at 0.667 -- ranking 110th of 208 Electronic Equipment stocks.
  • MRAM, RESN, and GILT are the stocks whose asset turnover ratios are most correlated with VREX.

The table below shows VREX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-02 0.667 0.316 0.034
2021-04-02 0.637 0.268 -0.019
2021-01-01 0.639 0.260 -0.034
2020-10-02 0.669 0.258 -0.037
2020-07-03 0.715 0.281 -0.006
2020-04-03 0.752 0.315 0.030

VREX Price Target

For more insight on analysts targets of VREX, see our VREX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $19.00 Average Broker Recommendation 1.38 (Strong Buy)

VREX Stock Price Chart Interactive Chart >

Price chart for VREX

VREX Price/Volume Stats

Current price $22.90 52-week high $32.65
Prev. close $22.80 52-week low $18.90
Day low $22.66 Volume 131,500
Day high $23.13 Avg. volume 367,850
50-day MA $21.40 Dividend yield N/A
200-day MA $25.99 Market Cap 911.42M

Varex Imaging Corporation (VREX) Company Bio


Varex Imaging Corporation. spun off from Varian Medical Systems, is focused on being a high-volume manufacturer of X-ray tubes, flat panel detectors and high-voltage connectors as well as a supplier of imaging software and specialized accelerators for high-energy x-ray imaging.


VREX Latest News Stream


Event/Time News Detail
Loading, please wait...

VREX Latest Social Stream


Loading social stream, please wait...

View Full VREX Social Stream

Latest VREX News From Around the Web

Below are the latest news stories about Varex Imaging Corp that investors may wish to consider to help them evaluate VREX as an investment opportunity.

Varex Imaging's (VREX) CEO Sunny Sanyal on Q1 2022 Results - Earnings Call Transcript

Varex Imaging Corporation (VREX) Q1 2022 Earnings Conference Call February 8, 2022 5:00 PM ET Company Participants Christopher Belfiore – Director-Investor Relations Sunny Sanyal – President and Chief Executive Officer Sam Maheshwari – Chief Financial Officer Conference Call Participants Larry Solow – CGS Securities Suraj Kalia – Oppenheimer & Company...

SA Transcripts on Seeking Alpha | February 9, 2022

Why Are Varex Imaging Shares Tumbling Today?

Varex Imaging Corporation (NASDAQ: VREX ) reported Q1 FY22 sales of $198.8 million , up from $177.1 million a year ago and missing the consensus of $208.27 million. Operating cash flow was $11 million. At the end of the first quarter, cash equivalents improved by $13 million sequentially to $158 million. Varex''s revenues decreased 12% sequentially, with both the medical and industrial segments declining from Q4 FY21. Compared to Q1 FY21, total … Full story available on Benzinga.com

Benzinga | February 9, 2022

Doximity, Aptevo top healthcare gainers; Varex Imaging, BioCardia among losers

Doximity DOCS +20%. Aptevo Therapeutics APVO +17%. Varex Imaging (VREX) -11%. BioCardia (BCDA) -8%.

Seeking Alpha | February 9, 2022

Varex Imaging (VREX) Q1 2022 Earnings Call Transcript

VREX earnings call for the period ending December 31, 2021.

The Motley Fool | February 9, 2022

Varex Imaging''s (VREX) CEO Sunny Sanyal on Q1 2022 Results - Earnings Call Transcript

Varex Imaging Corporation (NASDAQ:VREX) Q1 2022 Earnings Conference Call February 8, 2022 5:00 PM ET Company Participants Christopher Belfiore – Director-Investor Relations Sunny Sanyal –…

Seeking Alpha | February 8, 2022

Read More 'VREX' Stories Here

VREX Price Returns

1-mo 14.56%
3-mo -4.62%
6-mo -21.17%
1-year -8.73%
3-year -13.65%
5-year -34.40%
YTD -27.42%
2021 89.15%
2020 -44.05%
2019 25.89%
2018 -41.05%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6638 seconds.